Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

US Court Finds Bayer AG’s Yaz Contraceptive Patent Claims Invalid-Reuters


Tuesday, 16 Apr 2013 01:04pm EDT 

Reuters reported that a federal appeals court has ruled against Bayer AG, reversing a ruling by a lower court and finding that parts of a patent for the Company’s Yaz oral contraceptive were invalid. The United States Court of Appeals for the Federal Circuit ruled on April 16, 2013 that a district court in Nevada had erred in finding two claims of a patent for the contraceptive to be not invalid. It reversed the ruling. The patent expires on June 30, 2014. 

Company Quote

95.41
-2.28 -2.33%
15 Aug 2014